powered by
Newsletter Archive
Blog Sites
LC Exhibiting at Bio International Convention 2012
Are you attending the BIO International Convention 2012 in Boston next month? Bio International is one of biotech's largest conventions which brings together leaders in the industry from around the world. At the 2011 BIO International Convention in Washington we provided Spanish and Russian interpreting during several sessions and meetings with government officials. This year we expect to not only provide interpreting and translation services, but we will also be an exhibitor. The very nature of the meeting and the fact that there are many international delegates attending makes communication a key factor. In order for presentations and discussions to proceed effectively and smoothly, interpreters must be of the highest caliber. Don't risk being misunderstood!
Come visit our booth #2711 and let us know if you need
any language services including interpreters for your panel sessions. As an
official language service provider to BIO 2012, we are happy to serve you.
Universal Doctor: Multilingual Healthcare
H1N1 Vaccine Production Renewed in India
However, after the recent increase in H1N1 incidence in India, the Indian Health Ministry ordered the production of two million doses of the vaccine from Panacea Biotech (according to company representatives). Despite the relative increase in demand for the vaccine, some Indian companies, such as India's sole manufacturer of nasal swine flu vaccine, the Serum Institute, are tentative about scaling up production. Following the initial serge in 2009 when companies could not produce enough vaccine to keep up with the demand, the Serum Institute was forced to destroy two million doses last year. As a result of this experience, they have limited their production to 200,000 doses this year.
On a side note, Mexico also experienced an increased incidence in H1N1 infection more recently. especially between December 2011 and February 2012. Those affected were primarily older patients, a different age group from that most affected by the original epidemic.
Resources:
Visit our website at www.languageconnections.com!
Biotech Regulatory News: Genetically Modified Animals
http://www.npr.org/2012/01/02/144330629/biotech-firms-caught-in-regulatory-no-mans-land
Visit our website at www.languageconnections.com !
Webinar Cultural Adaptation in Clinical Trials
Language A Barrier to Health Care Benefits in California
Language barriers could deter more than 100,000
Californians from enrolling in the state's Health Benefit Exchange Program, according to a recent study conducted by the California Pan-Ethnic Health Network, the UCLA
Center for Health Policy Research, and the UC Berkeley Center for Labor
Research and Education. The study projects that in California more than one million adults with
limited-English proficient (LEP) will be eligible to receive tax
credits to allow them to purchase affordable coverage; however, only 42 % of eligible LEP adults are expected to enroll in the
program.
In California, more than 15 million residents speak
a language other than English at home, and nearly half of them have
limited proficiency in English. These statistics indicate the importance of adopting a strategy to improve community outreach and education. Of the population eligible for tax credits, 48 % are Latinos, 2 % are Native Americans, 4 % are African Americans, 32% are Caucasians and 14% are Asian American and Pacific
Islanders. Although the issue is one of education for many populations, in many cases the language barrier is a major contributing factor.
The Health Benefit Exchange Program will help to lower the cost
of health insurance for all Californians, and will be particularly helpful for working families that are in need of greater resources. However, in order for all state residents to benefit from such a program, they must enroll. Special measures must be taken to reach out to California's linguistically and culturally diverse populations in order to ensure their participation in the program, including providing materials and media in their own native language(s). The success in implementing this program will therefore depend not only on the number of people enrolled, but also on the state’s ability to
reach those individuals who might benefit but may not have the language skills to
participate.
References:
http://www.sjbeez.org/articles/2012/03/13/language-barriers-could-dampen-exchange-enrollment/
http://www.examiner.com/health-in-los-angeles/language-impairment-could-impact-health-benefit-exchange-enrolment
Visit our website at www.languageconnections.com
BiotechCorp & Quintiles Team Up in Malaysia
The recent announcement of a new partnership between
Malaysia's BiotechCorp and Quintiles East Asia branch this past month is
further evidence of Malaysia's promising biotech industry. US-based biopharma
services company Quintiles is collaborating with the Malaysia's leading biotech
development agency, Biotechnology Corporation (BiotechCorp), as part of
BiotechCorp’s efforts to expand their scope into the country's clinical
research sector.The merger is expected to bring a new level of interest to
Malaysia's already flourishing clinical research industry.
Among other things, the agreement between the two companies includes establishing a training program for clinical research, stem cell research, and vaccines in the Malaysian branch. Moreover, in conjunction with government support, BiotechCorp wants to address Malaysia's public health needs. Finally, the merger is expected to help improve infrastructure as well as bring greater expertise, in order to raise the country's clinical research capabilities. Quintiles, first opened offices in the Asia Pacific region in 1993. Then, in July 2010, the company formed a partnership with the University of Malaysia as an initial effort to strengthen the country's clinical research infrastructure by collaborating with large medical institutions involved in clinical research.
Analysts predict that Malaysia's biotech industry has enormous potential, and therefore we will be seeing greater collaboration between Western and Malaysia companies, especially in the clinical research sector.
References
http://www.thepharmaletter.com/file/111946/biotechcorp-quintiles-team-up-to-steer-malaysias-biotech-industry-to-greater-.html
Visit our website at www.languageconnections.com
Language Connections at Bio International 2012
Best Practices 2012 for Drug Trademarks
According to experts, Between 1980 and 2010, the number of pharmaceutical trademarks filed increased over 300%. Although 238,010 pharmaceutical trademarks were filed globally in 2010, there were only 21 new drugs approved by the FDA and 14 new molecular entities approved by the EMA. In 2011, the U.S. FDA's approval of new drugs was the ...
Argentina's Pharma Market: GBI Executive Summary Report
Argentina is one of the fast growing pharmaceutical markets in Latin America. It has an approximate revenue share of 10% of the total Latin American pharmaceutical market, and the third largest
market in Latin America.